c(MyD-4-4)

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug Namec(MyD-4-4)
Drug Alias Namec(MyD-4-4)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMyeloid differentiation primary response protein MyD88 inhibitors
TargetsMyeloid differentiation primary response protein MyD88
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHebrew University
China Registration ClassN/A

Develop Information

Active CompaniesHebrew University
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A